157 related articles for article (PubMed ID: 33363074)
21. Raising awareness of antimicrobial resistance in rural aquaculture practice in Bangladesh through digital communications: a pilot study.
Thornber K; Huso D; Rahman MM; Biswas H; Rahman MH; Brum E; Tyler CR
Glob Health Action; 2019; 12(sup1):1734735. PubMed ID: 32153258
[TBL] [Abstract][Full Text] [Related]
22. Community engagement: The key to tackling Antimicrobial Resistance (AMR) across a One Health context?
Mitchell J; Cooke P; Ahorlu C; Arjyal A; Baral S; Carter L; Dasgupta R; Fieroze F; Fonseca-Braga M; Huque R; Lewycka S; Kalpana P; Saxena D; Tomley F; Tsekleves E; Vu Thi Quynh G; King R
Glob Public Health; 2022 Nov; 17(11):2647-2664. PubMed ID: 34882505
[TBL] [Abstract][Full Text] [Related]
23. Systems thinking based approaches to engage with health inequities shaping Antimicrobial Resistance in low and lower-middle-income countries.
Mukherjee AS; Sahay S
J Infect Public Health; 2023 Dec; 16 Suppl 1():129-133. PubMed ID: 37977980
[TBL] [Abstract][Full Text] [Related]
24. Differential Drivers of Antimicrobial Resistance across the World.
Vikesland P; Garner E; Gupta S; Kang S; Maile-Moskowitz A; Zhu N
Acc Chem Res; 2019 Apr; 52(4):916-924. PubMed ID: 30848890
[TBL] [Abstract][Full Text] [Related]
25. Editorial: Antimicrobial Stewardship in Low- and Middle-Income Countries.
Gyssens IC; Wertheim HF
Front Public Health; 2020; 8():617000. PubMed ID: 33344409
[No Abstract] [Full Text] [Related]
26. Combating Global Antibiotic Resistance: Emerging One Health Concerns in Lower- and Middle-Income Countries.
Nadimpalli M; Delarocque-Astagneau E; Love DC; Price LB; Huynh BT; Collard JM; Lay KS; Borand L; Ndir A; Walsh TR; Guillemot D;
Clin Infect Dis; 2018 Mar; 66(6):963-969. PubMed ID: 29346620
[TBL] [Abstract][Full Text] [Related]
27. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health Index.
Zhou N; Cheng Z; Zhang X; Lv C; Guo C; Liu H; Dong K; Zhang Y; Liu C; Chang YF; Chen S; Guo X; Zhou XN; Li M; Zhu Y
Infect Dis Poverty; 2022 Aug; 11(1):92. PubMed ID: 35996187
[TBL] [Abstract][Full Text] [Related]
28. Co-designing community-based interventions to tackle antimicrobial resistance (AMR): what to include and why.
Mitchell J; Arjyal A; Baral S; Barrington D; Cooke P; Fieroze F; Huque R; Hamade P; Hawkings H; Jones N; Latham S; Parajuli A; Saify MB; King R;
BMC Res Notes; 2023 Oct; 16(1):290. PubMed ID: 37875996
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: a cross-sectional study of nationally representative facility-based and household-based surveys.
Fink G; D'Acremont V; Leslie HH; Cohen J
Lancet Infect Dis; 2020 Feb; 20(2):179-187. PubMed ID: 31843383
[TBL] [Abstract][Full Text] [Related]
30. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries.
Allwell-Brown G; Hussain-Alkhateeb L; Kitutu FE; Strömdahl S; Mårtensson A; Johansson EW
Lancet Glob Health; 2020 Jun; 8(6):e799-e807. PubMed ID: 32446345
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of antibiotics prescription amongst patients with and without COVID-19 in low- and middle-income countries: a systematic review and meta-analysis.
Satria YAA; Utami MS; Prasudi A
Pathog Glob Health; 2023 Jul; 117(5):437-449. PubMed ID: 36562085
[TBL] [Abstract][Full Text] [Related]
32. Appraising Nigeria's approach to combating antimicrobial resistance.
Onah SI; Umar HJ
Int J Health Plann Manage; 2024 Mar; 39(2):556-562. PubMed ID: 37846033
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial resistance in the Pacific Island countries and territories.
Loftus M; Stewardson A; Naidu R; Coghlan B; Jenney A; Kepas J; Lavu E; Munamua A; Peel T; Sahai V; Tekoaua R; Tudravu L; Zinihite J; Cheng A; Rafai E; Peleg A
BMJ Glob Health; 2020 Apr; 5(4):. PubMed ID: 32349993
[TBL] [Abstract][Full Text] [Related]
34. BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
Berman D; Neale R
J Antimicrob Chemother; 2021 Dec; 77(1):3-4. PubMed ID: 34791279
[TBL] [Abstract][Full Text] [Related]
35. A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.
Singh S; Charani E; Devi S; Sharma A; Edathadathil F; Kumar A; Warrier A; Shareek PS; Jaykrishnan AV; Ellangovan K
Antimicrob Resist Infect Control; 2021 Feb; 10(1):32. PubMed ID: 33573697
[TBL] [Abstract][Full Text] [Related]
36. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
[TBL] [Abstract][Full Text] [Related]
37. Global Antimicrobial Stewardship with a Focus on Low- and Middle-Income Countries.
Pierce J; Apisarnthanarak A; Schellack N; Cornistein W; Maani AA; Adnan S; Stevens MP
Int J Infect Dis; 2020 Jul; 96():621-629. PubMed ID: 32505875
[TBL] [Abstract][Full Text] [Related]
38. A multivariable analysis of the contribution of socioeconomic and environmental factors to blood culture Escherichia Coli resistant to fluoroquinolones in high- and middle-income countries.
Booth A; Wester AL
BMC Public Health; 2022 Feb; 22(1):354. PubMed ID: 35183144
[TBL] [Abstract][Full Text] [Related]
39. Investigating the impact of poverty on colonization and infection with drug-resistant organisms in humans: a systematic review.
Alividza V; Mariano V; Ahmad R; Charani E; Rawson TM; Holmes AH; Castro-Sánchez E
Infect Dis Poverty; 2018 Aug; 7(1):76. PubMed ID: 30115132
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic use prior to seeking medical care in patients with persistent fever: a cross-sectional study in four low- and middle-income countries.
Ingelbeen B; Koirala KD; Verdonck K; Barbé B; Mukendi D; Thong P; El Safi S; Van Duffel L; Bottieau E; van der Sande MAB; Boelaert M; Chappuis F; Jacobs J
Clin Microbiol Infect; 2021 Sep; 27(9):1293-1300. PubMed ID: 33188934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
